Pantoprazole Sodium

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

164 API Suppliers, 58 USDMF, 49 CEP/COS, 51 EU WC, 19 KDMF, 31 NDC API, 85 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

6 Drugs in Development

6 Drugs in Development

INTERMEDIATES

34 Intermediate Suppliers

34 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

1081 FDF Dossiers, 69 FDA Orange Book, 571 Europe, 40 Canada, 122 Australia, 71 South Africa, 208 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

POWDER;INTRAVENOUS - EQ 40MG BASE/VIAL, TABLET, DELAYED RELEASE;ORAL - EQ 20MG BASE, TABLET, DELAYED RELEASE;ORAL - EQ 40MG BASE, INJECTABLE;INTRAVENOUS - EQ 40MG BASE/VIAL

RELATED EXCIPIENT COMPANIES

1 Minakem, 12 Evonik, 1 Rochem International Inc, 21 SPI Pharma, 7 DKSH, 7 Boai NKY Pharmaceuticals Ltd, 6 Gangwal Healthcare, 8 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 2 Pfanstiehl, 4 Kirsch Pharma, 1 ACG Worldwide, 6 Actylis, 2 Aeon Procare, 2 Alcedo Pharmachem, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 1 Avesta Pharma, 35 BASF, 2 Clariant, 16 Corel Pharma Chem, 6 DFE Pharma, 3 Doshion Polyscience, 1 Esteem Industries, 2 Finar, 13 Gangwal Chemicals, 13 Ideal Cures, 4 Ingredion Pharma Solutions, 26 Kerry, 2 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 14 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 4 Novo Excipients, 5 Pharmatrans-Sanaq, 5 Pluviaendo, 2 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 21 Roquette, 14 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 3 Silverline Chemicals, 2 The Dow Chemical Company, 2 Ulanqab Kema New Material, 3 Valens Pharmachem, 3 Vasa Pharmachem, 1 Vertellus

EXCIPIENTS BY APPLICATIONS

76 Coating Systems & Additives, 73 Fillers, Diluents & Binders, 46 Direct Compression, 40 Controlled & Modified Release, 38 Disintegrants & Superdisintegrants, 36 Solubilizers, 34 Granulation, 34 Thickeners and Stabilizers, 33 Taste Masking, 25 Film Formers & Plasticizers, 23 Chewable & Orodispersible Aids, 22 Lubricants & Glidants, 21 Topical, 21 Parenteral, 14 Co-Processed Excipients, 10 Emulsifying Agents, 7 Surfactant & Foaming Agents, 6 API Stability Enhancers, 6 Rheology Modifiers, 5 Empty Capsules, 5 Coloring Agents, 4 Vegetarian Capsules

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 63 News #PharmaBuzz

GLOBAL SALES INFORMATION

38 US Medicaid Prescriptions, 408 Regulatory FDF Prices, 10 Annual Reports

MARKET PLACE

70 APIs, 55 FDF Dossiers

PATENTS & EXCLUSIVITIES

5 US Patents, 1 US Exclusivities, 17 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 24 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 20988 / DOSAGE - INJECTABLE;INTRAVENOUS - EQ 40MG BASE/VIAL

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
PANTOPRAZOLE SODIUM(UNII: 6871619Q5X) (PANTOPRAZOLE - UNII:D8TST4O562)	PANTOPRAZOLE	40mg in 10

Inactive Ingredients

Ingredient Name	Camber Pharmaceuticals, Inc.	Cardinal Health	Civica, Inc.	Fresenius Kabi USA, LLC	Novadoz Pharmaceuticals LLC	Teva Pharmaceuticals USA, Inc.	Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.
EDETATE DISODIUM(7FLD91C86K)
SODIUM HYDROXIDE(55X04QC32I)

Setid 5b5ddedd D429 41a7 8573 10c3e9ad4e52 Applno 20988 Form Injectable Intravenous Dosage Eq 40mg Base Vial - Drug Product Composition: Pantoprazole Sodium